1. Home
  2. ADPT
  3. ADPT News

Latest Adaptive Biotechnologies Corporation (ADPT) News on February 22, 2025

ADPT

MT Newswires

3 days ago

Adaptive Biotechnologies Insider Sold Shares Worth $3,985,754, According to a Recent SEC Filing

Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank
ADPT

TipRanks

8 days ago

Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank

Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations
ADPT

Simply Wall St.

9 days ago

Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations

Adaptive Biotechnologies (ADPT) Moves to Buy: Rationale Behind the Upgrade
ADPT

Zacks

10 days ago

Adaptive Biotechnologies (ADPT) Moves to Buy: Rationale Behind the Upgrade

ADPT

Thomson Reuters StreetEvents

10 days ago

Q4 2024 Adaptive Biotechnologies Corp Earnings Call

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
ADPT

Zacks

10 days ago

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ...
ADPT

GuruFocus.com

10 days ago

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ...

Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
ADPT

Zacks

11 days ago

Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates
ADPT

Zacks

11 days ago

Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates

ADPT

MT Newswires

11 days ago

Adaptive Biotechnologies' Q4 Loss Narrows, Revenue Rises

ADPT

Associated Press Finance

11 days ago

Adaptive Biotechnologies: Q4 Earnings Snapshot

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
ADPT

GlobeNewswire

11 days ago

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Preview: What To Look For
ADPT

GuruFocus.com

12 days ago

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Preview: What To Look For

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
ADPT

GlobeNewswire

17 days ago

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

PhaseV and Alimentiv to support execution of adaptive clinical trials for GI
ADPT

Clinical Trials Arena

18 days ago

PhaseV and Alimentiv to support execution of adaptive clinical trials for GI

The 5.4% return this week takes Adaptive Biotechnologies' (NASDAQ:ADPT) shareholders one-year gains to 99%
ADPT

Simply Wall St.

24 days ago

The 5.4% return this week takes Adaptive Biotechnologies' (NASDAQ:ADPT) shareholders one-year gains to 99%

Why Adaptive Biotechnologies Corporation (ADPT) Is Skyrocketing Now
ADPT

Insider Monkey

a month ago

Why Adaptive Biotechnologies Corporation (ADPT) Is Skyrocketing Now

Why Is Andreas Halvorsen Bullish On Adaptive Biotechnologies Corporation (ADPT) Now?
ADPT

Insider Monkey

a month ago

Why Is Andreas Halvorsen Bullish On Adaptive Biotechnologies Corporation (ADPT) Now?

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
ADPT

GlobeNewswire

a month ago

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
ADPT

Zacks

a month ago

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
ADPT

Zacks

a month ago

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?

ADPT

MT Newswires

a month ago

Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
ADPT

GlobeNewswire

a month ago

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025
ADPT

GlobeNewswire

a month ago

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025

Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ADPT

GlobeNewswire

2 months ago

Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
ADPT

Zacks

2 months ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging BellRing Brands (BRBR) This Year?
ADPT

Zacks

2 months ago

Are Medical Stocks Lagging BellRing Brands (BRBR) This Year?

Adaptive unveils data of MRD assessment test in blood cancer treatment
ADPT

Medical Device Network

2 months ago

Adaptive unveils data of MRD assessment test in blood cancer treatment

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions
ADPT

GlobeNewswire

2 months ago

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area
ADPT

Clinical Trials Arena

3 months ago

Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting
ADPT

GlobeNewswire

3 months ago

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?
ADPT

Zacks

3 months ago

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?

Novotech report notes shift to adaptive designs in clinical trials
ADPT

Clinical Trials Arena

3 months ago

Novotech report notes shift to adaptive designs in clinical trials

Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know
ADPT

Zacks

3 months ago

Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know

Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?
ADPT

Zacks

3 months ago

Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?

Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations
ADPT

Simply Wall St.

3 months ago

Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations

ADPT

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Adaptive Biotechnologies Corp Earnings Call

Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...
ADPT

GuruFocus.com

3 months ago

Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...

Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ADPT

Zacks

3 months ago

Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates
ADPT

Zacks

3 months ago

Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates

ADPT

Associated Press Finance

3 months ago

Adaptive Biotechnologies: Q3 Earnings Snapshot

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results
ADPT

GlobeNewswire

3 months ago

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
ADPT

GlobeNewswire

3 months ago

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result
ADPT

GuruFocus.com

4 months ago

Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result

November 2024's Top US Penny Stocks With Growth Potential
ADPT

Simply Wall St.

4 months ago

November 2024's Top US Penny Stocks With Growth Potential

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024
ADPT

GlobeNewswire

4 months ago

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?
ADPT

Zacks

5 months ago

Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?

Parametric company Adaptive Insurance launches operations
ADPT

Life Insurance International

5 months ago

Parametric company Adaptive Insurance launches operations

ADPT

MT Newswires

6 months ago

Adaptive Biotechnologies Receives IVDR Certification for clonoSEQ

Adaptive Announces IVDR Certification for clonoSEQ® in European Union
ADPT

GlobeNewswire

6 months ago

Adaptive Announces IVDR Certification for clonoSEQ® in European Union

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
ADPT

GlobeNewswire

6 months ago

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Adaptive Biotechnologies (ADPT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ADPT

Zacks

7 months ago

Adaptive Biotechnologies (ADPT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
ADPT

Zacks

7 months ago

Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates

ADPT

Associated Press Finance

7 months ago

Adaptive Biotechnologies: Q2 Earnings Snapshot

Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
ADPT

GlobeNewswire

7 months ago

Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss
ADPT

Simply Wall St.

7 months ago

Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss

Adaptive builds automation tools to speed up construction payments
ADPT

TechCrunch

7 months ago

Adaptive builds automation tools to speed up construction payments

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
ADPT

GlobeNewswire

7 months ago

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains?
ADPT

Zacks

7 months ago

uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains?

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
ADPT

Yahoo Finance Video

8 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

ADPT

GlobeNewswire

8 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
ADPT

Reuters

8 months ago

California seeks company profits in Big Oil climate lawsuit

ADPT

USA TODAY

8 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
ADPT

Business Wire

8 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
ADPT

GlobeNewswire

8 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
ADPT

GlobeNewswire

8 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
ADPT

Business Wire

8 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
ADPT

GlobeNewswire

9 months ago

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
ADPT

GlobeNewswire

9 months ago

Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

ARK Invest's Cathie Wood Snags These 3 Bargains — Are They Right for Your Portfolio?
ADPT

Benzinga

9 months ago

ARK Invest's Cathie Wood Snags These 3 Bargains — Are They Right for Your Portfolio?

The Agency by AGI Denim Elevates Adaptive Denim
ADPT

Sourcing Journal

9 months ago

The Agency by AGI Denim Elevates Adaptive Denim

Adaptive Biotechnologies First Quarter 2024 Earnings: Beats Expectations
ADPT

Simply Wall St.

9 months ago

Adaptive Biotechnologies First Quarter 2024 Earnings: Beats Expectations

Why Adaptive Biotechnologies Topped the Market Today
ADPT

Motley Fool

9 months ago

Why Adaptive Biotechnologies Topped the Market Today

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript
ADPT

Insider Monkey

9 months ago

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript

ADPT

GuruFocus.com

9 months ago

Adaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics
ADPT

Zacks

9 months ago

Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics

ADPT

GuruFocus.com

9 months ago

Adaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst Challenges

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates
ADPT

Zacks

9 months ago

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates

ADPT

Associated Press Finance

9 months ago

Adaptive Biotechnologies: Q1 Earnings Snapshot

Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
ADPT

GlobeNewswire

9 months ago

Adaptive Biotechnologies Reports First Quarter 2024 Financial Results

PhaseV and Quanticate partner to help sponsors run more adaptive trials
ADPT

Clinical Trials Arena

10 months ago

PhaseV and Quanticate partner to help sponsors run more adaptive trials

Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
ADPT

GlobeNewswire

10 months ago

Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue

Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024

Team behind popular Falcon AI models unveils new startup with $20 million in funding aimed at helping companies tailor LLMs for business
ADPT

Fortune

a year ago

Team behind popular Falcon AI models unveils new startup with $20 million in funding aimed at helping companies tailor LLMs for business

Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript
ADPT

Insider Monkey

a year ago

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript

ADPT

Thomson Reuters StreetEvents

a year ago

Q4 2023 Adaptive Biotechnologies Corp Earnings Call

Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment
ADPT

GuruFocus.com

a year ago

Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment

ADPT

Associated Press Finance

a year ago

Adaptive Biotechnologies: Q4 Earnings Snapshot

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results

Here’s Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4
ADPT

Insider Monkey

a year ago

Here’s Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4

Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS
ADPT

Zacks

a year ago

Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS

Appellate Court Upholds District Court Denial of SmartSky's Attempt to Prevent Gogo Business Aviation from Selling its 5G Solution
ADPT

PR Newswire

a year ago

Appellate Court Upholds District Court Denial of SmartSky's Attempt to Prevent Gogo Business Aviation from Selling its 5G Solution

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024

Starbucks (SBUX) Reports Q1: Everything You Need To Know Ahead Of Earnings
ADPT

StockStory

a year ago

Starbucks (SBUX) Reports Q1: Everything You Need To Know Ahead Of Earnings

SunOpta (STKL) Increases Despite Market Slip: Here's What You Need to Know
ADPT

Zacks

a year ago

SunOpta (STKL) Increases Despite Market Slip: Here's What You Need to Know

Biotech’s First IPO of 2024 Popped 96%. Good Times Could Be Ahead for the Stocks.
ADPT

Barrons.com

a year ago

Biotech’s First IPO of 2024 Popped 96%. Good Times Could Be Ahead for the Stocks.

ADPT

Thomson Reuters StreetEvents

a year ago

Q4 2023 ConnectOne Bancorp Inc Earnings Call

Byline Bancorp Inc (BY) Reports Solid Growth in 2023 Earnings
ADPT

GuruFocus.com

a year ago

Byline Bancorp Inc (BY) Reports Solid Growth in 2023 Earnings

Share on Social Networks: